PlainRecalls
FDA Drug Critical Class I Terminated

Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg per 50 mL (4 mcg per mL), for intravenous infusion, preservative free, 50 mL Single Dose Bottle, Rx only, Fresenius Kabi Lake Zurich, IL 60047, NDC 63323-671-05

Reported: September 2, 2020 Initiated: July 22, 2020 #D-1537-2020

Product Description

Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg per 50 mL (4 mcg per mL), for intravenous infusion, preservative free, 50 mL Single Dose Bottle, Rx only, Fresenius Kabi Lake Zurich, IL 60047, NDC 63323-671-05

Reason for Recall

Cross Contamination with other products: trace amounts of lidocaine

Details

Recalling Firm
Fresenius Kabi USA, LLC
Units Affected
25,100 bottles
Distribution
U.S.A. Nationwide
Location
Lake Zurich, IL

Frequently Asked Questions

What product was recalled?
Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg per 50 mL (4 mcg per mL), for intravenous infusion, preservative free, 50 mL Single Dose Bottle, Rx only, Fresenius Kabi Lake Zurich, IL 60047, NDC 63323-671-05. Recalled by Fresenius Kabi USA, LLC. Units affected: 25,100 bottles.
Why was this product recalled?
Cross Contamination with other products: trace amounts of lidocaine
Which agency issued this recall?
This recall was issued by the FDA Drug on September 2, 2020. Severity: Critical. Recall number: D-1537-2020.